1147 5-year follow-up of 998 chronic hepatitis B patients to determine long-term safety of lamivudine and clinical consequences of lamivudine-resistant mutations
Autor: | Lok, Anna S., Lai, Ching-Lung, Leung, Nancy, Yao, Guang-Bi, Cui, Zhen-Yu, Schiff, Eugene R., Dienstag, Jules L., Heathcote, Jenny, Little, Nancy R., Griffiths, Dorothea A., Gardner, Stephen D., Castiglia, Mary |
---|---|
Zdroj: | In Hepatology 2003 38 Supplement:708-708 |
Databáze: | ScienceDirect |
Externí odkaz: |